RxDoctor Payments Data

Jared Feyko, DO

Vascular Surgery · Easton, PANPI 1518257674

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (40.5%), travel and lodging and grants — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Medtronic at 41.9% of the total. Reporting peaked in 2019 at $6,240 and has fallen 84.4% since, to $975 in 2025.

$16,922in general payments, 2019–2025

Across 139 payments — averaging $121.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$7K
  • Inari Medical, Inc.$2K
  • Terumo Medical Corporation$2K
  • W. L. Gore & Associates, Inc.$857
  • Cook Medical LLC$753
  • Endologix LLC$613
  • plus $4K from 15 others

What the payments were for

  • Grants$4,00024%
  • Travel & lodging$5,70534%
  • Food & beverage$6,85641%
  • Education$3612%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,922 in reported general payments places this provider in the 80th percentile of 236 vascular surgery providers in Pennsylvania.

See all vascular surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$215,085
Medicare patients
2,201
Services billed
3,195

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate14$156
Atorvastatin Calcium13$144
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen18$131

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Easton

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →